Cargando…
Association of serum neurofilament light with microglial activation in multiple sclerosis
BACKGROUND: Translocator protein (TSPO)-PET and neurofilament light (NfL) both report on brain pathology, but their potential association has not yet been studied in multiple sclerosis (MS) in vivo. We aimed to evaluate the association between serum NfL (sNfL) and TSPO-PET-measurable microglial acti...
Autores principales: | Saraste, Maija, Matilainen, Markus, Vuorimaa, Anna, Laaksonen, Sini, Sucksdorff, Marcus, Leppert, David, Kuhle, Jens, Airas, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447382/ https://www.ncbi.nlm.nih.gov/pubmed/37130728 http://dx.doi.org/10.1136/jnnp-2023-331051 |
Ejemplares similares
-
High serum neurofilament associates with diffuse white matter damage
in MS
por: Saraste, Maija, et al.
Publicado: (2020) -
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies
por: Martin, Sarah-Jane, et al.
Publicado: (2019) -
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
por: Lie, Ingrid Anne, et al.
Publicado: (2022) -
Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials
por: Harris, Sarah, et al.
Publicado: (2021) -
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis
por: Adams, Ashok, et al.
Publicado: (2022)